✦ LIBER ✦

Erratum: Current understanding of fungal microflora in inflammatory bowel disease pathogenesis

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 396 KB
Volume: 18
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.22880

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current understanding of fungal microflo

Current understanding of fungal microflora in inflammatory bowel disease pathogenesis

✍ David Underhill; Jonathan Braun 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Inflammatory bowel diseases are a current and growing public health problem, with a prevalence that appears to be increasing in most countries and cultures. While most research into the triggering phenomenon has focused on the interaction between commensal bacteria and inflammatory bowel disease, en

Mouse models of intestinal inflammation

Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease

✍ Holm H. Uhlig; Fiona Powrie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Chemoprophylaxis of colorectal cancer in

Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts

✍ Jonathan S. Levine; Robert Burakoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa

Lost in translation: Helping patients un

Lost in translation: Helping patients understand the risks of inflammatory bowel disease therapy

✍ Corey A. Siegel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Patients with inflammatory bowel disease are commonly treated with immunomodulators and biologic therapy. These treatments can be very effective, but are associated with risks of adverse events that need to be discussed with patients. Effectively communicating risks of therapy can be challenging bas

Role of flagellin in Crohn's disease: Em

Role of flagellin in Crohn's disease: Emblematic of the progress and enigmas in understanding inflammatory bowel disease

✍ Matam Vijay-Kumar; Andrew T. Gewirtz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Elevated immune responses to the enteric microbiota have long been associated with inflammatory bowel disease (IBD), especially Crohn's disease. In recent years there has been considerable progress in identifying a number of the specific bacterial and host molecules whose interactions mediate these

The straw that stirs the drink: Insight

The straw that stirs the drink: Insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice

✍ Bruce H. Horwitz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

Abnormal response to enteric microflora is a critical factor driving bowel inflammation in patients with inflammatory bowel disease (IBD). Mice with genetically engineered mutations have played a central role in both formulating this hypothesis and elucidating the mechanism that normally protect the